Proactive Therapeutic Concentration Monitoring of Infliximab May Improve Outcomes for Patients with Inflammatory Bowel Disease

Authors:
Open Access
Publisher website
Google Scholar
Abstract
Background. Infliximab (IFX) is effective in the treatment of inflammatory bowel disease; however, the effect is often not durable. It is unknown if proactive t

This publication has 26 references indexed in Scilit: